Towa Pharmaceutical
World Rank (Aug-2026)
7,528
Market Cap (Aug-2026)
1.478 Billion USD
World Rank (Jan-05-2024)
9,674
Market Cap (Jan-05-2024)
0.817 Billion USD
World Rank (Jul-30-2023)
11,308
Market Cap (Jul-30-2023)
0.629 Billion USD
World Rank (Dec-25-2022)
9,673
Market Cap (Dec-25-2022)
0.789 Billion USD
World Rank (Jan-07-2022)
8,326
Market Cap (Jan-07-2022)
1.24 Billion USD
Annual Revenue in USD
1,208 Million USD
Annual Net Income in USD
116 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Company Profile
Towa Pharmaceutical manufactures and distributes pharmaceutical products and it focused on the products like neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins and hormone drugs. The company annual revenue is 154,900 million JPY and annual net income is 13,958 million JPY for year ending March 2021. The headquarters is in Japan.
Company Website